On December 26-27, 2023, the "Whale Integrity and Win-Win Future" Double Whale Pharmaceutical 2023 National Strategic Partner Summit (Winter) was held in Zhuhai, attended by company leaders such as Long Wancheng, KA team, OTC provincial teams, relevant functional personnel, and 113 partners from across the country.

At the beginning of the conference, General Long first delivered a speech, reviewing the work of 2023, introducing the marketing logic of Double Whale Children's Vitamin D, Calcium Zinc, Double Whale Calcium, and Adult Vitamin D, as well as the latest progress in brand planning investment, research and development, and production operations, reiterating the commitment to continue adhering to the "three-in-one, dual-wheel drive, brand empowerment" marketing partner model.

General Long pointed out that soaring eagles do not associate with low-priced private labels. The economic situation in 2023 is complex, yet many regions have still achieved good results. The company has verified through sales practice the correctness of "brand + high-margin sales," thus gaining more confidence to face private label competition.

General Long emphasized that people are the foundation of sales service, and the construction of partner teams must keep pace with the company's brand empowerment and market penetration, sharing the latest team building situation of the company.

General Long stated that currently, the economy is entering a weak cycle, and Double Whale Pharmaceutical looks forward to advancing new strategic plans, joining hands with national partners to strengthen confidence, recreate super products in the industry, and collectively break free from the economic weak cycle.

The company's Vice General Manager and General Manager of the Market Center, Zi Ludong, delivered a speech titled "Embrace Certainty, Cross Weak Cycles," systematically elaborating on corporate and brand strategies, sales and product strategies through a series of industry data analyses.

General Zi pointed out that the company will focus on bone health products in the future, gradually occupying consumer mindsets by providing representative bone nutrition products needed by adults and children, establishing the brand image of "Bone Nutrition Expert," and striving to make Double Whale a leader in the field of bone health in China within the next 10 years.

General Zi stated that in an increasingly saturated market environment with more and more pharmacies, only good brand support, good products, and coordinated sales strategies can find leverage in the fierce competition at retail terminals.

The OTC Marketing Department's Sheng Haokun shared the competitive environment and strategies for Double Whale Calcium and Adult Vitamin D in 2024, pointing out that the silver economy market is vast, and Adult Vitamin D will fully develop as the second pillar besides calcium preparations in pharmacies, while Double Whale Calcium D will leverage the main brand construction of bone nutrition experts to comprehensively attack the current calcium preparation market.

The OTC Marketing Department's Wu Guangxin introduced the competitive environment and strategies for Double Whale Children's Vitamin D and Calcium Zinc in 2024, pointing out that refined parenting is mainstream, and Children's Vitamin D will maintain reasonable growth through stock competition, while Calcium Zinc will serve as the main carrier for the Double Whale brand.

The General Manager of the OTC Division, Ni Shuai, presented a review of the 2023 OTC operation situation through internal sales data analysis, introducing the sales system of service partners and terminal markets; he proposed to improve the business model, platform structure, and enhance organizational capabilities to achieve the 2024 goal of "initially forming a systematic retail business around Double Whale Bone Nutrition Expert with multiple varieties and channels."

In addition, General Ni also detailed the six major work focuses to achieve the 2024 goals, emphasizing the need for localized strategies, personalized development, and scientific resource output to comprehensively enhance terminal service capabilities.

The General Manager of the National KA Platform, Li Sen, presented a review and analysis of the KA business development situation in 2023, including the Hundred Regiments War, and systematically introduced the 2024 KA work goals and key strategies. He stated that in 2024, they will enhance the strategic docking capabilities of NKA, strengthen the marketing of Double Whale Bone Nutrition nodes, and actively create sample markets.

Wang Xinwen, Director of the Hospital Division, shared on-site, reviewing and analyzing the development of hospital market projects, activities, and the macro market environment in 2023, and proposed work goals and strategy plans for 2024. He stated that an expert team will be established in the adult field to fully implement the company's "Bone Nutrition Expert" strategy.

Outstanding partner representatives Ji Liyang, Pan Suling, Min Jie, Wang Junqiang, and others were invited to share excellent case studies.

Mr. Ma Chenggong, Senior Consultant of Xiaomi Warehouse Academy and former Executive Principal of JD University, was invited to the scene to empower national partners from the perspective of corporate organizational change.

During the summit, the company also held an awards dinner to commend partners who performed excellently in 2023.

This National Strategic Partner Summit is a grand event held by the company during a special period when the economy is shifting to a weak cycle and the pharmaceutical industry is facing weak growth. It not only introduced the company's latest development plans to partners but also strengthened communication, enhanced confidence, and built consensus. It is believed that in 2024, under the correct leadership of the company's decision-making level, the company will surely leap over the dragon gate and achieve remarkable results!